All articles tagged with #testosterone replacement therapy
A growing trend among young men without diagnosed hormonal deficiencies involves self-administering testosterone injections to enhance physical appearance and perceived masculinity. This practice, known as 'testmaxxing,' bypasses medical oversight and carries significant health risks, including infertility and cardiovascular issues, despite the belief that it optimizes natural performance.
Actor Josh Duhamel, 53, has publicly endorsed testosterone replacement therapy (TRT) after discovering low levels in his early 40s. He co-founded Gatlan, a men's health company, despite warnings from former representatives that the venture could damage his image. Duhamel reports feeling stronger and more energetic, injecting testosterone three times weekly. Experts caution that TRT is for medical deficiency, not performance enhancement, and carries risks including infertility and blood clots.
Actor Josh Duhamel, 53, stated on the 'Human Upgrade' podcast that testosterone replacement therapy (TRT) has improved his physical health and energy levels, allowing him to feel better than he did in his 30s. Duhamel began TRT approximately five years ago after discovering low testosterone levels in his early 40s. He co-founded Gatlan, a men's health company offering hormone optimization and longevity treatments, despite warnings from former representatives that the venture could harm his public image. Duhamel injects testosterone three times weekly to maintain consistent levels, citing benefits for joint pain, back strength, and overall vitality. He emphasized that the therapy helps him keep up with his three young children, including a 3-month-old daughter and a 2.5-year-old son. Duhamel advocates for broader public discussion on hormone optimization, noting that medical science supports these treatments for longevity and quality of life. The FDA has approved testosterone products for men with low testosterone associated with specific medical conditions, though it requires warnings regarding potential increased blood pressure.
Defense Secretary Pete Hegseth announced a plan to screen U.S. military personnel over 30 for testosterone levels and offer replacement therapy to optimize performance. While the FDA has recently eased restrictions on testosterone replacement therapy (TRT) following new clinical data, medical experts warn that the policy conflates normal aging with medical deficiency. Critics argue the initiative promotes harmful misconceptions about masculinity and ignores the complex risks of TRT, including cardiovascular issues and infertility, while supporters view it as a necessary step for maintaining combat readiness.
A federal judge ordered the Pentagon to explain why its new plan to screen cisgender soldiers 30+ for testosterone and offer testosterone replacement therapy differs from its ban on transgender troops, requesting the medical rationale, cost, and implementation details before an August 7 hearing as doctors warn of TRT risks and lawmakers scrutinize the policy amid ongoing transgender-service lawsuits.
US Defense Secretary Pete Hegseth proposes annual testosterone deficiency screening for all service members aged 30 and over, with voluntary testosterone replacement therapy for those with low levels; under-30 personnel can opt in for testing, while the Pentagon has not clarified therapy access for women. The move is tied to a broader push to ease testosterone prescribing, a policy angle highlighted by the BBC as reflecting a more “manly” military.
The Pentagon will screen service members aged 30 and over for low testosterone, prompting a broader discussion of what testosterone truly means for health and performance. The piece explains normal ranges, how levels rise and fall with sleep, weight, and stress, and that treatment is appropriate for truly deficient men but carries risks such as fertility loss and cardiovascular effects. It notes that boosting testosterone in healthy, young soldiers often doesn’t improve performance, while replacement can help older men who are genuinely deficient. Current guidelines favor testing symptoms over universal screening, though some argue early testing could foster better overall health engagement; the core takeaway is that testosterone is a health marker, not a shortcut to better performance.
The Defense Department will add testosterone testing for service members aged 30 and older to the annual health assessment, with voluntary testosterone replacement therapy for those with low levels. Hegseth says the goal is to optimize natural performance, but critics warn that blanket screening isn’t evidence-based, testosterone levels vary over time, and the policy could affect readiness and how it intersects with fitness standards and gender in combat roles.
An in-depth look at the surge in testosterone testing and replacement therapy driven by online clinics and ads. The piece questions whether “low T” is being medicalized through looser diagnostic thresholds, as patients report real benefits while endocrinologists warn of overdiagnosis, marketing-driven care, and uncertain long‑term risks for otherwise healthy men.
Country star Jelly Roll says Testosterone Replacement Therapy helped his weight loss, alongside better diet and exercise; experts caution TRT isn’t a weight‑loss drug but can improve energy, metabolism, and body composition for men with low testosterone when paired with healthy habits, with proper testing and ongoing monitoring.
A Telegraph investigation shows aggressive ads for testosterone replacement therapy on the London Underground, pushing the idea that many men have low testosterone. Experts say such claims exaggerate prevalence, and using TRT without medical need can raise health risks like blood clots, strokes, infertility and addiction. Regulators (ASA, MHRA) are reviewing industry practices after past advertising breaches, and a study from Imperial College London notes a surge in online clinics promoting testosterone treatment with insufficient diagnostic testing. A first-person piece by a journalist who tested his own levels found normal results, underscoring that not all men need TRT and urging caution against internet-driven hype.
Male menopause, also known as andropause, is characterized by a decline in testosterone levels as men age, with about three in 10 men in their 70s and 80s suffering from low testosterone. Symptoms include reduced libido, fatigue, mood changes, hot flashes, erectile dysfunction, infertility, and reduced muscle mass. Testosterone replacement therapy and lifestyle changes can help replenish hormones, but experts emphasize the need for balanced lifestyle, exercise, healthy diet, and good sleep to maintain healthy testosterone levels.
A man shares his experience with low libido and grumpiness, which was diagnosed as depression but turned out to be low testosterone levels. He found relief through testosterone replacement therapy, although the FDA warns against its use in older men due to potential risks. Another reader asks about over-the-counter treatments for nail fungus, and the authors suggest trying soaking feet in Listerine or using an OTC antibiotic ointment. Lastly, a person on Remicade for eight years developed a severe scalp rash, which may be scalp psoriasis triggered by the medication, according to a recent study.
Fitness influencer Jo Lindner, who suffered from rippling muscle disease (RMD), expressed concerns about the long-term effects of testosterone replacement therapy (TRT) just days before his death at the age of 30 due to an aneurysm. Lindner had spoken about his condition in a podcast, highlighting worries about the impact on his heart.
Jo Lindner, a popular German bodybuilding influencer known as "Joesthetics," has passed away at the age of 30. His girlfriend confirmed on social media that he died from an aneurysm after complaining of neck pain. In his final post, Lindner discussed his gym journey and the long-term effects of testosterone replacement therapy. His girlfriend described him as an amazing and incredible person.